close
MENU
Hot Topic NBR Focus: GMO
Hot Topic NBR Focus: GMO
Investment
4 mins to read

Scuppered Ebos deal ‘disappointing’, ‘a real shame’ 

Although one market source suggests the terms were ‘stretchy’ at best.

Key points
  • What's at stake: Ebos had been in a trading halt since last Thursday following speculation it was eyeing the acquisition of pets and vets business Greencross.
  • Background: Private equity firm TPG took Greencross private in 2019 at A$5.55 a share and later sold a 45% stake to AustralianSuper and The Healthcare of Ontario Pension Plan in early 2022 in a deal that valued that company at more than A$3.5 billion. 
  • Main players: Ebos, Greencross, AustralianSuper, The Healthcare of Ontario Pension Plan, Matt Goodson, Greg Smith, NZX.

The last-minute collapse of a potential multi-billion-dollar acquisition by dual-listed healthcare product company Ebos has been labelled “disappointing” and a “real shame” for New Zealand’s capital market.

Last Thursday, Ebos went into a trading halt after the Australian Financial

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

NZ$399.00 / yearly

Offer ends July 31st

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Hamish McNicol Thu, 23 Nov 2023
Contact the Writer: Hmcnicol@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Key points
  • What's at stake: Ebos had been in a trading halt since last Thursday following speculation it was eyeing the acquisition of pets and vets business Greencross.
  • Background: Private equity firm TPG took Greencross private in 2019 at A$5.55 a share and later sold a 45% stake to AustralianSuper and The Healthcare of Ontario Pension Plan in early 2022 in a deal that valued that company at more than A$3.5 billion. 
  • Main players: Ebos, Greencross, AustralianSuper, The Healthcare of Ontario Pension Plan, Matt Goodson, Greg Smith, NZX.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Scuppered Ebos deal ‘disappointing’, ‘a real shame’ 
Investment,
101789
true